Solutions for Life Sciences
In the highly-regulated life sciences industry, accuracy, quality and time-to-market
are vital in the pursuit of global markets. SDL has expertise in the technology,
services and processes required for this industry.
Pharmaceutical and Biopharmaceutical Industry
Fierce competition and a pressing need for revenue replacements, at a time when patent expiration hands business over to generics manufacturers, forces pharmaceutical companies to introduce new products on an international scale quicker and more effectively.
In these challenging times, it is critical for pharmaceutical companies to achieve excellence throughout the entire product cycle from discovery, preclinical, clinical, regulatory approval and commercialisation process, Any improvement in terms of time to market have enormous financial impact. Analyst firm Cutting Edge Information estimates that each additional day a drug spends in development can cost a company from $600,000 to $8 million in lost revenue.
SDL has pioneered significant business process improvements applying Global Information Management best practices to clinical, regulatory (including PIM) and the commercialization processes.
There is a an untapped business opportunity for drug manufacturers to professionalize the mandatory local language delivery to patients, doctors, pharmacists, regulators, ethic committees, health care providers, and safety experts.
Medical Devices, Medical Equipment and Medical Supply
The accelerated aging of world population drives the need for cardiovascular and respiratory devices. Minimally invasive surgery and the emerging neurostimulation segment as well as other high-growth areas including therapeutic devices, endoscopy, infusion systems, diagnostic and monitoring equipment, audiology, and instrumentation devices are experiencing high product innovation and technological advancement cycles with trends such as wireless capabilities for hospitals and remote patient monitoring.
Despite ongoing growth, medical devices manufacturers are threatened by government efforts to reduce ever increasing healthcare costs pushing for higher competition in the market place. Today, on every medical devices executive's agenda you will find:
- Increasing R&D costs - Shorter product lifecycles
- Driving cost down whilst maintaining Compliance
- Increased regulatory requirements
- Lengthy documentation procedures and increase time to market
個案研究
Agfa HealthCare 個案研究
透過建置 SDL MultiTerm 來管理企業術語，以及採用 SDL Passolo 進行視覺軟體本地化，Agfa HealthCare 已大幅提高本地化的內容品質，從 75% 提高到 95%，同時也讓新醫療解決方案的上市速度加快 60%。
Global Information Management solution from SDL helps perfect new European healthcare standard
The following case study looks at how SDL’s Global Information Management System (GIM) has enabled the European Medicines Agency (EMEA) and GlaxoSmithKline (GSK) to work together to help perfect the new European healthcare standard,Product Information Management, and create a streamlined, efficient process for the approval of new drugs and product
Win-win situation for Schering AG with SDL Global Information Management Solutions
"The really attractive aspect of SDL is the fact that it builds on human intelligence. Computers have excellent memories. By capturing past human translations in a computer- resident translation memory, we combine the best of both worlds."
解決方案介紹
SDL Language Services Data Sheet-Life Sciences
With SDL language services, life sciences corporations can be assured of the efficient translation of content from any language into any language - at high quality and low cost. With more than 50 offices in 30 countries, SDL has the furthest reaching infrastructure in the translation, localization and GIM markets.
SDL 服務解決方案 - 將您的全球資訊資產安心交給 SDL
SDL 在全球超過 30 個國家設立辦公室網絡，而且具備觸角範圍寬廣的基礎架構，能提供超過 120 種不同語言的高品質翻譯服務。 閱讀更多 SDL 可以提供的各種服務類型。
Pharmaceutical and Biopharmaceutical Industry
While maintaining strict adherence to regulatory requirements, pharmaceutical companies
are pressured to improve product pipelines and to accelerate time to global markets.
Medical Devices
With ever-decreasing product lifecycles and the globalization of manufacturing
operations, the need to develop and deliver product content rapidly in local
languages has become increasingly important.
Regulatory Approval - Labeling
For most Life Sciences organizations, the multilingual labeling process is
experienced as painful, slow and error-prone. In Europe, global labeling
becomes a multilingual labeling issue considering the English to non-English
ratio of source to target language for labeling submissions.
Clinical Trials
Clinical trials are the most time-consuming and labor-intensive part of the approval process
for a new drug. Because of this they are often undertaken in multiple countries simultaneously.
Clinical trials involve hundreds or thousands of discrete documents and modular data prior
to completion for approval of a marketing authorization.
